in this issue
Regions :: North America
Private equity firm acquires Cambridge Major for $212 million
January 2, 2013 | Deepti Ramesh
Cambridge Major Laboratories (CML; Germantown, WI), a producer of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), and private equity firm American Capital (Bethesda, MD) say that American Capital has invested $212 million to acquire CML. CML was a portfolio company of private equity firm Arlington Capital Partners (Washington) prior to American Capital's investment. American Capital brings significant resources, relationships, and capital to fuel CML's growth, both organically and through acquisition, CML says. “The management...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee